Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?

Subjects

Subjects :

Neuroendocrine Tumors
Hypertension, Renal
Antineoplastic Agents, Hormonal
Carcinoma, Medullary
Animals
Humans
Kidney Failure, Chronic
Yttrium Radioisotopes
Receptors, Somatostatin
Thyroid Neoplasms
Radiopharmaceuticals
Octreotide

Details

ISSN :

12341010

Volume :

8

Issue :

4

Database :

OpenAIRE

Journal :

Medical science monitor : international medical journal of experimental and clinical research

Accession number :

edsair.pmid..........3bf03eece5c9c52cff9debfca869df0c